{"id":594,"date":"2015-08-28T20:20:51","date_gmt":"2015-08-28T20:20:51","guid":{"rendered":"http:\/\/medicalrhetoric.com\/symposium2015\/?page_id=594"},"modified":"2015-08-28T20:20:51","modified_gmt":"2015-08-28T20:20:51","slug":"keynote-segal","status":"publish","type":"page","link":"https:\/\/medicalrhetoric.com\/symposium2015\/schedule\/keynote-segal\/","title":{"rendered":"Keynote: Segal"},"content":{"rendered":"<p>Learn more about <a href=\"http:\/\/medicalrhetoric.com\/symposium2015\/featured-speakers\/judy-segal\/\">Judy<\/a> and her current work.<\/p>\n<p><strong>Sex and the rhetoric of drugs: faux feminism at the FDA and how it won the day. <a href=\"http:\/\/medicalrhetoric.com\/symposium2015\/wp-content\/uploads\/2015\/09\/segal_keynote.pptx\">segal_keynote<\/a><br \/>\n<\/strong><\/p>\n<p>For the discussion to follow Judy&#8217;s talk, she has provided the following questions for consideration:<\/p>\n<p>1. There has been a shift recently in medicine and in medicine studies from talking about medical humanities to talking about health humanities.\u00a0 What is the significance of the shift and what might it mean for those of us who work on discourses of health and medicine?<\/p>\n<p>2. At professional conferences and in publications in rhetoric\/composition\/technical-writing\/communication journals, we talk mostly to each other about the rhetoric of health and medicine.\u00a0 Whom else should we be talking to\u2014and how might we create the conditions in which we can talk to those people?\u00a0 Who is\/are the audience\/s for your own work?<\/p>\n<p>3. Where do analysis and commentary end and activism begin?\u00a0 Is academic writing itself a form of (symbolic) action?<\/p>\n<p>4. What, if any, responsibility do we have to make situations better when we believe that they need to be\u2014and what qualifies us to know when a situation needs to be better, and what \u201cbetter\u201d means in that case?<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Learn more about Judy and her current work. Sex and the rhetoric of drugs: faux feminism at the FDA and how it won the day. segal_keynote For the discussion to follow Judy&#8217;s talk, she has provided the following questions for &hellip; <a href=\"https:\/\/medicalrhetoric.com\/symposium2015\/schedule\/keynote-segal\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"parent":9,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"onecolumn-page.php","meta":{"footnotes":""},"class_list":["post-594","page","type-page","status-publish","hentry"],"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/medicalrhetoric.com\/symposium2015\/wp-json\/wp\/v2\/pages\/594","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicalrhetoric.com\/symposium2015\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/medicalrhetoric.com\/symposium2015\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/medicalrhetoric.com\/symposium2015\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/medicalrhetoric.com\/symposium2015\/wp-json\/wp\/v2\/comments?post=594"}],"version-history":[{"count":0,"href":"https:\/\/medicalrhetoric.com\/symposium2015\/wp-json\/wp\/v2\/pages\/594\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/medicalrhetoric.com\/symposium2015\/wp-json\/wp\/v2\/pages\/9"}],"wp:attachment":[{"href":"https:\/\/medicalrhetoric.com\/symposium2015\/wp-json\/wp\/v2\/media?parent=594"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}